Cenra

Cenra FCF Yield

The Free Cash Flow Yield of Cenra (3716.TW) as of Oct 22, 2026 is 10.42 %. In the previous year, Free Cash Flow Yield was 8.50 % — a change of 22.53% (higher).

FCF Yield

10.42 %

YoY

22.53%

Last updated:

Free Cash Flow Yield of Cenra is 2025 10.42 % . Free Cash Flow Yield of Cenra was 2024 8.50 % . It decreases by 22.53% higher compared to the previous year.

The Cenra FCF Yield history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Yield
Date
FCF Yield
Jan 1, 2018
-1.08 TWD
Jan 1, 2019
-3.20 TWD
Jan 1, 2020
12.52 TWD
Jan 1, 2021
9.60 TWD
Jan 1, 2022
-2.04 TWD
Jan 1, 2023
6.69 TWD
Jan 1, 2024
8.50 TWD
Jan 1, 2025
10.42 TWD
The Cenra FCF Yield history
YEARFCF YieldYoY
10.42 %+22.53%
8.50 %+27.01%
6.69 %-427.65%
-2.04 %-121.27%
9.60 %-23.28%
12.52 %-491.57%
-3.20 %+196.22%
-1.08 %-116.71%
6.46 %+623.92%
0.89 %-81.58%
4.84 %+495.84%
0.81 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cenra Stock analysis

What does Cenra do? Cenra Inc generates revenue through its subsidiaries that develop, manufacture, and sell pharmaceuticals, agricultural and livestock drugs, personal hygiene, and health products. The company offers human medicines including prescription, over-the-counter, and disease treatment products, medical equipment such as blood pressure monitors and blood glucose meters, animal medicines and feed additives, and daily necessities like oral hygiene products, hand sanitizers, and skin care items. These products are sold under the company's own brand portfolio, targeting consumers, healthcare providers, and veterinary markets. The company's business model focuses on integrated product development and distribution across multiple health and wellness segments. Cenra Inc's product segments include human pharmaceuticals, medical devices, animal health solutions, and personal care items. The human medicine segment covers prescription and over-the-counter drugs, while medical devices include blood pressure monitors and artificial joints. Animal health products consist of medicines, supplementary feeds, and feed additives for disease prevention and nutrition. Personal care products range from oral hygiene to skin care, targeting individual consumers seeking health and wellness solutions. The company's revenue streams are derived from direct sales of these diverse product categories to end-users and healthcare institutions. The company's subsidiaries handle the full value chain from development to sales, ensuring control over product quality and market positioning. By offering a comprehensive range of health-related products, Cenra Inc serves multiple customer segments including individual consumers for personal care, hospitals and clinics for medical equipment, and veterinary clinics for animal health products. This diversified approach allows the company to leverage cross-selling opportunities and maintain steady revenue streams across different market segments. Cenra is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cenra stock

Free Cash Flow Yield of Cenra is 10.42 % in 2025.

Free Cash Flow Yield of Cenra changed from 8.50 % to 10.42 %, representing a 22.53% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow Yield Cenra since 2006 – with annual values, charts, and detailed analysis.

FCF Yield measures the free cash flow per share relative to the stock price. It indicates how much cash a company generates for each dollar invested.

To evaluate Free Cash Flow Yield's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Free Cash Flow Yield.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow Yield's Cenra with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Cenra

All Key Metrics — Cenra